DOT Drug & Alcohol Testing Glossary

DOT drug and alcohol testing regulations span hundreds of pages of federal code. The terms matter — using the wrong one in a policy, a record, or a conversation with a compliance officer can create real problems. This glossary covers the terms you'll encounter most often when managing a DOT drug testing program or going through the testing process as a driver.

Definitions are based on 49 CFR Part 40 (DOT testing procedures), FMCSA 49 CFR Part 382, and related agency guidance. When in doubt, consult the actual federal regulations.

Actual Knowledge

Direct evidence — observed by a supervisor or employer — that an employee used, possessed, or was impaired by drugs or alcohol while performing a safety-sensitive function. Actual knowledge is a DOT violation even without a positive test result and triggers the full return-to-duty process.

Adulterated Specimen

A urine specimen that contains a substance not normally present in human urine, or one with a pH or other property outside acceptable ranges that indicates tampering. An adulterated specimen result is treated as a refusal to test under 49 CFR Part 40.

BAC (Blood Alcohol Concentration)

The percentage of alcohol in a person's bloodstream, expressed as grams per deciliter (g/dL). In DOT alcohol testing, a BAC of 0.04 or higher is a violation that triggers removal from safety-sensitive duty. A BAC of 0.02–0.039 requires removal for a minimum of 24 hours but is not a formal DOT violation.

BAT (Breath Alcohol Technician)

A federally certified professional trained to operate an Evidential Breath Testing (EBT) device and conduct DOT-compliant breath alcohol tests. BATs must complete DOT-specified training and proficiency demonstration. Unlike drug test collectors who are "qualified," BATs are specifically "certified" per DOT regulation.

CCF (Custody and Control Form)

The five-part federal form (OMB No. 0930-0158) used to document every DOT urine specimen collection. It tracks the specimen from the collection site through the laboratory to the MRO, establishing an unbroken chain of custody. Using the correct CCF is required; non-federal forms cannot be used for DOT testing.

CDL (Commercial Driver's License)

A state-issued license required to operate commercial motor vehicles (CMVs) above certain weight thresholds or carrying hazardous materials or passengers for hire. CDL holders operating in interstate commerce are subject to FMCSA drug and alcohol testing requirements under 49 CFR Part 382.

Clearinghouse (FMCSA Drug & Alcohol Clearinghouse)

A federally mandated database maintained by FMCSA that records CDL driver DOT drug and alcohol violations, SAP evaluations, and return-to-duty completions. Employers must query the Clearinghouse before hiring a CDL driver and conduct annual queries on current drivers. Drivers cannot return to safety-sensitive duties at any employer without the Clearinghouse reflecting a completed RTD process.

CMV (Commercial Motor Vehicle)

A vehicle used in commerce that meets one of the following: (1) gross vehicle weight rating or combination weight of 26,001 lbs or more; (2) designed to transport 16 or more passengers including the driver; (3) transports hazardous materials in a quantity requiring placarding. Driving a CMV in interstate commerce is a safety-sensitive function requiring DOT drug and alcohol testing.

Collector (DOT Urine Specimen Collector)

A person trained and qualified under 49 CFR Part 40 to collect urine specimens for DOT drug testing. Collectors must complete DOT-approved training, pass a mock collection proficiency test, and stay current on recertification. The term is "qualified collector" — not certified, as the federal regulation uses "qualified" for this role.

C/TPA (Consortium / Third-Party Administrator)

An entity that provides DOT drug and alcohol testing services on behalf of employers — managing random selection pools, scheduling collections, coordinating MRO services, and maintaining compliance records. C/TPAs are especially useful for small employers who cannot cost-effectively run their own random testing programs. BBB Mobile works with C/TPAs and can provide collection services for employers enrolled in a C/TPA program.

Direct Observation Collection

A urine specimen collection conducted with a same-gender observer watching the urine leave the donor's body. Required for: return-to-duty tests, follow-up tests, tests where the collector observes indicators of tampering, and tests ordered by the MRO for certain shy bladder situations. Not used for routine pre-employment or random tests unless specific circumstances apply.

DOT (Department of Transportation)

The U.S. federal agency that issues and enforces drug and alcohol testing regulations for safety-sensitive transportation employees. DOT's testing procedures are codified in 49 CFR Part 40. Separate modal agencies (FMCSA, FAA, FRA, FTA, PHMSA, USCG) set industry-specific requirements but all use Part 40 collection and testing procedures.

EBT (Evidential Breath Testing Device)

A DOT-approved device used to measure blood alcohol concentration from a breath sample. EBTs must appear on the NHTSA Conforming Products List to be used in DOT testing. The device prints a result record that becomes part of the alcohol testing documentation. Preliminary screening devices (ASDs) may be used for the initial screening step but an EBT is required for any confirmation test.

Five-Panel Drug Test

The standard DOT urine drug test, which screens for five categories of substances: marijuana (THC metabolites), cocaine, opiates (including heroin, codeine, morphine, and semi-synthetics), amphetamines (including methamphetamine and MDMA), and phencyclidine (PCP). DOT testing does not include alcohol, benzodiazepines, or other substances unless required by specific program rules.

Follow-Up Testing

Unannounced drug and/or alcohol tests required after a driver completes the return-to-duty process. The Substance Abuse Professional determines the schedule: at minimum 6 tests in the first 12 months, potentially extending up to 5 years total. Follow-up tests are always directly observed and are separate from — and in addition to — the employer's regular random testing draws.

FMCSA (Federal Motor Carrier Safety Administration)

The DOT modal agency responsible for regulating commercial motor vehicle safety, including CDL drug and alcohol testing programs. FMCSA sets the annual random testing rates (currently 50% for drugs, 10% for alcohol), maintains the Drug and Alcohol Clearinghouse, and enforces 49 CFR Part 382 for motor carriers. Most trucking employers are regulated primarily under FMCSA.

MRO (Medical Review Officer)

A licensed physician trained in DOT drug testing procedures who reviews all positive, adulterated, substituted, and invalid laboratory results. The MRO contacts the donor to determine if there is a legitimate medical explanation for the result before reporting it to the employer. Only after MRO review is a lab result considered "verified" — positive or otherwise. Employers cannot receive raw lab results; all results come through the MRO.

Non-DOT Drug Test

A workplace drug test that does not follow 49 CFR Part 40 federal protocols — typically used for employees not in DOT-regulated positions or for non-safety-sensitive roles. Non-DOT tests may use different panels, cutoff levels, or collection procedures, and results do not go into the FMCSA Clearinghouse. Many employers run both DOT and non-DOT programs depending on employee roles.

Post-Accident Drug Test

A DOT-required drug and/or alcohol test conducted after a qualifying accident involving a CMV. FMCSA requires post-accident testing when: a fatality occurs (always required), a driver receives a citation AND there is an injury requiring immediate medical treatment away from the scene, or a driver receives a citation AND a vehicle is towed. The alcohol test must occur within 2 hours (and no later than 8 hours) of the accident; the drug test within 32 hours.

Pre-Employment Drug Test

A DOT-required drug test that must produce a verified negative result before a driver performs any DOT safety-sensitive function for the first time with a new employer. For FMCSA-regulated employers, a Clearinghouse query must also be completed before the pre-employment test is administered. The pre-employment test is always a urine drug test; a pre-employment alcohol test is not federally required (though permitted).

Qualified Collector

The regulatory term for a person trained to collect urine specimens for DOT drug testing under 49 CFR Part 40. The word "qualified" is precise: DOT uses "qualified" for collectors (not certified or licensed). To be qualified, a collector must complete a DOT-approved training program and demonstrate proficiency through monitored mock collections. BBB Mobile's collectors are qualified under this standard.

Random Testing

Unannounced DOT drug and/or alcohol tests selected by a scientifically valid random process, where each employee in the random pool has an equal chance of selection on any given draw. FMCSA currently requires employers to test at least 50% of their covered driver pool for drugs and 10% for alcohol annually. Being selected for random testing is not punitive — it is a routine compliance requirement.

Reasonable Suspicion Testing

A DOT-required test ordered when a trained supervisor has specific, articulable observations of an employee's appearance, behavior, speech, or body odors that are consistent with drug or alcohol use. The supervisor must have received DOT-mandated reasonable suspicion training (minimum 60 minutes for drugs, 60 minutes for alcohol). Only a trained supervisor — not a coworker or HR staff — can make the reasonable suspicion determination.

Refusal to Test

Under 49 CFR Part 40, a refusal to test is treated the same as a positive test result. Refusals include: failing to appear for a scheduled test, leaving the collection site before completing the process, failing to provide a sufficient specimen without a valid medical explanation, failing to sign the CCF, attempting to adulterate or substitute a specimen, and other behaviors defined in Part 40. A refusal triggers the return-to-duty process and must be reported to the Clearinghouse.

Return to Duty (RTD)

The process — and the specific test — required before a DOT safety-sensitive employee can resume regulated duties after a drug or alcohol violation. The process involves a SAP evaluation, completion of any prescribed treatment or education, and a directly observed negative drug and/or alcohol test. Return-to-duty tests and the surrounding process are documented in the FMCSA Clearinghouse.

Safety-Sensitive Function

Any job duty that directly affects transportation safety and subjects an employee to DOT drug and alcohol testing requirements. For FMCSA, this means operating a commercial motor vehicle. For other DOT agencies, it includes piloting aircraft (FAA), operating locomotives (FRA), controlling train movements (FRA), and other defined duties. An employee is in a safety-sensitive function from the time they begin a work period until they complete it — including breaks if they remain on duty.

SAMHSA (Substance Abuse and Mental Health Services Administration)

The federal agency within HHS that certifies laboratories to perform DOT drug testing. Only SAMHSA-certified (also called HHS-certified) laboratories may test DOT specimens. The list of certified labs is published on the SAMHSA website. Using a non-certified lab for DOT testing is a regulatory violation that can make results unenforceable.

SAP (Substance Abuse Professional)

A licensed clinical professional — licensed physician, licensed psychologist, licensed social worker, licensed professional counselor, or alcohol and drug counselor with specific credentials — who has completed DOT SAP training and qualification requirements. After a DOT violation, the SAP evaluates the employee, recommends treatment or education, and determines when the employee is eligible for return-to-duty testing. The SAP's role is evaluation and recommendation, not treatment provision.

Split Specimen

Each DOT urine collection yields two specimens from a single void: Bottle A (the primary specimen, sent to the lab for testing) and Bottle B (the split specimen, held sealed by the lab). If the MRO reports a positive, adulterated, or substituted result, the employee has the right to request that the split specimen (Bottle B) be tested by a second SAMHSA-certified laboratory. The split specimen test result can confirm or refute the primary result.

Substituted Specimen

A urine specimen with creatinine and specific gravity values so far outside normal physiological ranges that the specimen cannot be consistent with normal human urine. A substituted result means the specimen was replaced with something other than the donor's own urine. Substitution is treated as a refusal to test under 49 CFR Part 40, triggering the return-to-duty process.